# Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents

> **NCT00046501** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 250 (—)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Lantus (insulin glargine [rDNA origin] injection)
- **DRUG:** Humulin N
- **DRUG:** Humulin L
- **DRUG:** Lispro

## Key facts

- **NCT ID:** NCT00046501
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2005-02
- **Final completion:** —
- **Target enrollment:** 250 (—)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046501, "Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00046501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*